SGP 주가 차트
SGP 주가 예측
SpyGlass Pharma Inc
$0
0%
$0
종가: Aug 24, 16:00:00 GMT-4
$0
0%
$0
애프터마켓: Aug 24, 20:00:00 GMT-4
뒤로
SpyGlass Pharma Inc (SGP) 주가 예측
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
배당수익률
--
EPS(TTM)
--
시가총액
--
SGP란 무엇인가요?
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. The company is headquartered in Aliso Viejo, California and currently employs 65 full-time employees. The company went IPO on 2026-02-06. The firm is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.
